Author: ALLISON GATLIN
Source
Biogen earnings comfortably beat Q3 views. Sales also topped, with Alzheimer’s drug Leqembi picking up. Biogen stock rose slightly.
The post Biogen Earnings Top Views; Alzheimer’s Drug Leqembi Gaining Momentum appeared first on Investor’s Business Daily.